J P Morgan Chase & Co lowered shares of Opko Health Inc. (AMEX:OPK) from an overweight rating to a neutral rating in a report published on Thursday morning, StockTargetPrices.com reports.
Separately, Jefferies Group LLC reiterated a hold rating and set a $8.00 price objective on shares of Opko Health in a research report on Tuesday, June 13th.
Opko Health (AMEX OPK) opened at 5.97 on Thursday. The firm’s 50 day moving average price is $6.21 and its 200-day moving average price is $6.88. The stock’s market cap is $3.34 billion. Opko Health has a 52 week low of $5.85 and a 52 week high of $12.15.
Opko Health Company Profile
OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.
Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.